魚躍醫療(002223.SZ):擬發行GDR並申請在瑞士證券交易所掛牌上市
格隆匯11月22日丨魚躍醫療(002223.SZ)公佈,為滿足公司業務發展的需要,進一步提升公司核心競爭力和品牌影響力,根據相關監管要求,公司擬發行全球存託憑證(Global Depository Receipts,“GDR”),並申請在瑞士證券交易所(SIX Swiss Exchange)掛牌上市,GDR以新增發的公司人民幣普通股(A股)作為基礎證券。
為完成此次發行上市,公司擬根據相關法律法規的規定轉為境外募集股份有限公司,並根據GDR招股説明書所載條款及條件,向符合相關條件的投資者發行GDR。
公司此次發行GDR所代表的新增基礎證券A股股票不超過5012.3846萬股(包括因任何超額配股權獲行使而發行的證券(如有)),不超過此次發行前公司普通股總股本的5%。若公司股票在此次發行董事會決議日至發行日期間發生送股、資本公積金轉增股本、配股、股份分拆或者合併等除權行為,或者因股份回購、實施股權激勵計劃、可轉債轉股等導致發行時公司普通股總股本增加或者減少的,則此次發行GDR所代表的新增基礎證券A股股票的數量將按照相關規定進行相應調整。
最終發行數量提請股東大會授權董事會或董事會授權人士根據法律規定、監管機構批准及市場情況確定。
此次發行GDR的募集資金扣除發行費用後,擬用於公司核心業務進一步發展和戰略投資,包括但不限於優質標的的兼併收購及投資、建設境外研發中心及推進全球產品研發計劃,以及建設全球產品銷售網絡與售後服務體系。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.